CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Topical Moisturizerother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04045119
NCT04045119N/ACompleted
CompareCT.gov

Effect of a Facial Cream Containing 0.5% Cannabidiol and 0.1% Hemp Oil on Skin Hydration and Characteristics Associated Acne-prone Skin

Avicanna Inc·interventional·Posted Aug 5, 2019·Updated Apr 28, 2020

In Brief

A clinical study evaluating Topical Moisturizer for Cosmetic Acne. Completed, enrolled 54 participants across 1 site.

Detailed Summary

This research seeks to evaluate the short (i.e., after single application) and long-term (i.e., after periodic application) hydrating effect of a topical preparation containing CBD and hemp oil on facial skin as well as the effect on erythema, appearance, instrumentally measured sebum production and quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCosmetic Acne
CountriesColombia
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 5, 2019
Enrollment StartOct 1, 2019
Primary CompletionJan 2, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.9 years ago

Interventions

Topical Moisturizerother

The investigational product is a moisturizing facial cream for skin with imperfections that is applied topically and is manufactured by Avicanna Inc. This preparation contains widely used ingredients from mineral and botanical origin aimed at improving skin hydration and characteristics associated acne-prone skin. The moisturizer also contains 0.1% of hemp oil rich in essential fatty acids and antioxidants and 0.5% of cannabidiol with regulatory effect on the skin.